AstraZeneca
AZN
#47
Rank
โ‚ฌ240.15 B
Marketcap
77,46ย โ‚ฌ
Share price
0.17%
Change (1 day)
24.00%
Change (1 year)

AstraZeneca (AZN) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ28.02 Billion

According to AstraZeneca's latest financial reports the company's total debt is โ‚ฌ28.02 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AstraZeneca - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ28.93 B12.62%
2023-12-31โ‚ฌ25.69 B-5.42%
2022-12-31โ‚ฌ27.16 B0.26%
2021-12-31โ‚ฌ27.09 B63.54%
2020-12-31โ‚ฌ16.56 B1.83%
2019-12-31โ‚ฌ16.27 B-2.61%
2018-12-31โ‚ฌ16.70 B12.58%
2017-12-31โ‚ฌ14.84 B-7.12%
2016-12-31โ‚ฌ15.97 B16.07%
2015-12-31โ‚ฌ13.76 B54.42%
2014-12-31โ‚ฌ8.91 B18.66%
2013-12-31โ‚ฌ7.51 B-3.6%
2012-12-31โ‚ฌ7.79 B8.51%
2011-12-31โ‚ฌ7.18 B3.6%
2010-12-31โ‚ฌ6.93 B-10.21%
2009-12-31โ‚ฌ7.72 B845.27%
2008-12-31โ‚ฌ0.81 B-92.13%
2007-12-31โ‚ฌ10.38 B1019.91%
2006-12-31โ‚ฌ0.92 B-8.58%
2005-12-31โ‚ฌ1.01 B8.38%
2004-12-31โ‚ฌ0.93 B158.85%
2003-12-31โ‚ฌ0.36 B-55.24%
2002-12-31โ‚ฌ0.80 B-25.41%
2001-12-31โ‚ฌ1.08 B20.63%
2000-12-31โ‚ฌ0.89 B-19.3%
1999-12-31โ‚ฌ1.11 B15.96%
1998-12-31โ‚ฌ0.95 B-2.91%
1997-12-31โ‚ฌ0.98 B-5.73%
1996-12-31โ‚ฌ1.04 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Bristol-Myers Squibb
BMY
โ‚ฌ43.83 B 56.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ52.26 B 86.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ35.53 B 26.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ20.49 B-26.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
โ‚ฌ21.92 B-21.76%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
โ‚ฌ36.50 B 30.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ39.33 B 40.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ11.11 B-60.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ5.66 B-79.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ27.50 B-1.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland